Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Saturday, June 29, 2013

Ruxolitinib Boosts Survival In Patients With Myelofibrosis

Continuous ruxolitinib therapy extends survival over that seen with best available therapy in patients with myelofibrosis and also provides durable reductions in splenomegaly, according to results released at the 18th Congress of the European Hematology Association .

http://www.medicalnewstoday.com/articles/262671.php

No comments:

Post a Comment

Popular Stem Cell Roundup Posts